Skip to main content

Silo Pharma, Inc. (SILO) Stock

Silo Pharma, Inc. Stock Details, Movements and Public Alerts

Stock Details

Silo Pharma, Inc. (SILO), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $4.95. Over the past 52 weeks, it has ranged between $3.32 and $15.15. This places the current price at 32.7% of its 52-week high and 49.3% above its 52-week low. The 14-day Relative Strength Index (RSI) stands at 38.91, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $6.02 by 17.77%. Similarly, it is below its 200-day moving average of $6.35 by 22.05%. The MACD histogram is -0.17, indicating bearish momentum (MACD Line: -0.25, Signal Line: -0.08). There are currently 3 active alerts set for SILO by users.

52-Week Range

$15.15 - $3.32

-67.33% from high · +49.32% from low

Avg Daily Volume

428,660

20-day average

100-day avg: 3,156,953

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-6.83

Price to Book

0.91

EV/EBITDA

0.18

EPS (TTM)

-$5.85

Price to Sales

74.82

Beta

0.75

Less volatile than market

Q:How is SILO valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is SILO's risk profile compared to the market?
With a beta of 0.75, Silo Pharma, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 0.91 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-8846.44%

EBITDA

$-4,769,916

Return on Equity

-99.94%

Return on Assets

-46.27%

Revenue Growth (YoY)

0.00%

Q:How profitable and efficient is SILO's business model?
0 The operating margin of -8846.44% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -99.94% and ROA at -46.27%, the company achieves moderate returns on invested capital.
Q:What are SILO's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$5.4M

Revenue (TTM)

$72,102

Revenue/Share (TTM)

$0.10

Shares Outstanding

1.13M

Book Value/Share

$5.24

Asset Type

EQUITY

Q:What is SILO's market capitalization and position?
Silo Pharma, Inc. has a market capitalization of $5.4M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 1.13M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does SILO's price compare to its book value?
Silo Pharma, Inc.'s book value per share is $5.24, while the current stock price is $4.95, resulting in a price-to-book (P/B) ratio of 0.94. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Jul 17, 2026, 02:16 AM

Technical Indicators

RSI (14-day)

38.91

Neutral

50-Day Moving Average

$6.02

-17.77% below MA-50

200-Day Moving Average

$6.35

-22.05% below MA-200

MACD Line

-0.25

MACD Signal

-0.08

MACD Histogram

-0.17

Bearish

Q:What does SILO's RSI value tell investors?
The RSI (Relative Strength Index) for SILO is currently 38.91, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret SILO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.25 below the signal line at -0.08, with histogram at -0.17. This bearish crossover indicates downward pressure. The 50-day MA ($6.02) is below the 200-day MA ($6.35), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Jul 17, 2026, 09:14 AM

Active Alerts

Alert Condition
MA Breakout (Bullish)
Threshold
50 days
Created
Jul 16, 2026, 04:24 PM
Alert Condition
Volume change
Threshold
200%
Created
Jul 15, 2026, 03:59 PM
Alert Condition
RSI Threshold Cross
Threshold
30
Created
Jul 13, 2026, 04:27 PM

Stay Ahead of the Market with Silo Pharma, Inc. Alerts

Set up price alerts for Silo Pharma, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.